From a technical perspective applying RT-qPCR for resolving the status of ERBB2, ESR1, PGR, and MKI67 represents an efficient and reproducible alternative for decentralized routine assessment of breast cancer molecular subtypes. Here, ESR1 is linked to breast carcinoma.